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Abstract: 
Introduction: Suprascapular neuropathy (SSN) is rare, with an estimated 
prevalence of 4.3% in patients with shoulder pain.  
Methods: This retrospective chart review included patients with SSN seen during 
a 16-year period. Demographics and clinical information were recorded. 
Descriptive statistics including percentages, means, and standard deviations were 
computed for the variables of interest for all patients.   
Results:  Of 87 patients included in this study, trauma (n=27) was the most 
common cause of SSN followed by neuralgic amyotrophy (n=21). Fifty-seven 
patients had isolated SSN.  Other had SSN associated with axillary neuropathy (23 
patients), brachial plexopathy (3), and long thoracic, radial, or spinal accessory 
neuropathy (1 each).  
Discussion: SSN is commonly associated with axillary neuropathy. Trauma 
remains the most common cause of SSN. Electrodiagnostic findings aid in the 
initial diagnosis and may indicate the need for close clinical follow-up based on the 
severity of the axonal injury. 
Keywords: Suprascapular neuropathy, shoulder pain, shoulder weakness 
sports injury, proximal neuropathy, axillary neuropathy 
Suprascapular Neuropathy: A Review of 87 Cases 
Anza B. Memon M.D 1,3, Braydon Dymm M.D 2, Bashiruddin K. Ahmad M.D 1, 
Naganand Sripathi M.D 1, Lonni Schultz PhD 1, Arun Chandok M.D 1 
1 Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA 
2 Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA 
3 Wayne State University School of Medicine, Detroit, Michigan 
Introduction  
Suprascapular neuropathy (SSN) is an uncommon source of shoulder pain.   
Weakness of abduction and external rotation, and the associated functional 
disturbance, can result from impaired innervation of the supraspinatus and 
infraspinatus muscles, respectively.1 Severe denervation can lead to atrophy 
apparent on a physical exam as well as edema and fatty infiltration seen on 
imaging.2 
The prevalence of SSN ranges from 1-2% of all shoulder pain to 4.3% in patients 
with shoulder complaints referred to an academic center.3 Elite athletes engaging in 
overhead sports activities, such as volleyball, are at particularly high risk.4  
While SSN may rarely be a result of neuralgic amyotrophy (Parsonage-Turner 
syndrome), the most common cause relates to mechanical compression.5,6,7 
Common locations for compression include entrapment at the suprascapular notch 
by the superior transverse scapular ligament and at the spinoglenoid notch by the 
spinoglenoid ligament.8 Mass effect by a ganglion cyst may also occur.9 
As the predominant clinical feature of SSN is shoulder pain, it is important to 
include similarly presenting conditions in the differential diagnosis such as other 
proximal mononeuropathies, arthropathy, tendinopathy and radiculopathy. 10 
Electromyography (EMG) is the gold standard for the diagnosis of SSN4 and 
imaging may be helpful.  
The goal of this study was to better understand the clinical presentation, exam 
findings, etiology, and diagnostic studies in the evaluation of SSN and its 
association with other mononeuropathies. The secondary aim was to better 




Patients seen at the Henry Ford Health System between January 2000 and 
December 2016 with an EMG diagnostic code of SSN were identified via 
electronic medical records (EMR). The study was approved by the hospital’s 
institutional review board.  A retrospective chart review of patients with SSN was 
performed. Other mononeuropathies associated with SSN were recorded. 
Patient age at onset of symptoms gender, ethnicity, side of neuropathy etiology, 
risk factors, and clinical features was recorded. Electrophysiological studies, 
diagnostic evaluation, treatment (pain management and physical therapy), follow-
up, and recovery data were collected. A detailed history of clinical presentation 
including the presence of pain, medical research council (MRC) muscle scale 
functional impairment, atrophy of supraspinatus and infraspinatus muscles, and 
range of motion such as active forward flexion, abduction, and external rotation 
were noted.  Recovery was defined as improvement in MRC motor scale functional 
impairment, pain, and range of motion during follow-up.  Patients who had an 
initial clinic visit with no follow-up were classified as lost to follow-up. Potentially 
relevant risk factors for SSN were also recorded from the EMR which included 
shoulder trauma, falls, rotator cuff tear, rotator cuff surgeries, compression lesions, 
and repetitive overhead shoulder movements secondary to occupation or 
recreational activities.  
Electrophysiologic data included compound muscle action potential (CMAP) 
amplitude of suprascapular nerve recorded using a surface electrode over the 
infraspinatus muscle while stimulating at Erb’s point, and needle EMG data 
regarding fibrillation potentials and recruitment of motor unit action potentials 
(MUAPa) in the supraspinatus and/or infraspinatus muscles.  Fibrillation potentials 
were graded as being either present or absent.  Recruitment of MUAPs was 
classified as being normal or abnormal.  
Magnetic resonance imaging (MRI) and ultrasound of the shoulders were reviewed 
where available to identify structural or mass lesions (paralabral cyst, desmoid 
tumor), rotator cuff tear, shoulder dislocation (Hill-Sachs deformity), joint capsule 
hypertrophy, and supraspinatus and infraspinatus muscle atrophy.  
Statistical Analysis:  
Descriptive statistics were used for patient variables as well as subgroups. For 
comparisons of the SSN subgroups, chi-squared and Fisher’s exact tests were 
performed for categorical variables and a two-sample t-test was done for age at 
diagnosis.  Wilcoxon two-sample tests were used to compare the SSN subgroups 
for the duration of symptoms and CMAP amplitude because these variables did not 
meet the assumption of normality using the Shapiro-Wilk test for normality. 
Wilcoxon two-sample tests also were used for the measurements of supraspinatus 
and infraspinatus motor strength because they were measured on the ordinal scale 
MRC scale. Similar analyses were done to assess the association of recovery with 
CMAP amplitude and EMG findings recorded from supraspinatus and 
infraspinatus muscles. Statistical significance was set at p<0.05. All analyses were 
performed using SAS 9.4 (SAS Institute Inc, Cary, NC, USA).  
Results:  
Of 87 patients included in this study, 66% were male; 72% were Caucasian and 
22% were African American. The mean age at diagnosis was 47.4 years (range 14-
81 years). The most common cause of SSN was trauma from a motor vehicle 
accident (MVA) or fall (31%) followed by idiopathic and weight-lifting (Table 1). 
Patients with idiopathic etiology were confirmed cases of neuralgic amyotrophy 
This diagnosis was established based on the patient’s clinical presentation, in 
association with the exclusion of other potential causative factors by the examining 
physician.   
Of all patients, 57 had isolated SSN followed by SSN associated with axillary 
neuropathy (SSN+ axillary, n=23).   Additional patient characteristics can be found 
in Table 1.  The median duration of symptoms (time between the onset of 
symptoms and EMG) was 4.6 months.  Additional clinical and EMG information 
can be found in Table 2.  
A total of 14 patients were lost to follow-up.  Of the remaining 73 patients, the 
median follow-up time was 16.9 months (range 8 days to 13 years; interquartile 
range 3.7 to 52.4 months).  Nine of the patients without recovery had follow-up 
time less than 3 months and were not included in the recovery analysis.  Of the 
remaining 64 patients, 50 (78%) patients recovered with a median time to recovery 
of 8.2 months (interquartile range 4.8 to 13.5 months) and 45 of these recovered 
within 18 months.  The median duration of follow-up was 13.4 months 
(interquartile range 4.6 to 41.7 months) for the 14 patients without recovery.  
Details of patients by groups are shown in Supplementary Tables 1-3. Of the 87 
patients, 42 (48%) had an abnormal shoulder MRI and 37 (43%) had an abnormal 
shoulder ultrasound (Supplementary Table 1).  A comparison of patients with 
SSN+ axillary neuropathy versus isolated SSN showed a significant difference in 
etiology. Patients with isolated SSN were more likely to have sports-related and 
idiopathic etiologies while patients with SSN+ axillary neuropathy were more 
likely to have an etiology of trauma (MVA and falls). Patients with SSN + axillary 
neuropathy had a significantly higher rate of a limited range of motion compared to 
the isolated group. Significant differences were also found for supraspinatus 
weakness, with patients having no associated neuropathy demonstrating greater 
MRC values. (Supplementary Table 2.) The difference in CMAP amplitude 
between patients with and without recovery was not significant. The associations 
of recovery with EMG abnormalities (recruitment/fibrillation potentials) in 
supraspinatus and infraspinatus muscles were also not significant.  (Supplementary 
Table 3.) 
Only 17 of 87 patients had a repeat electrodiagnostic study. Of these, 11 recovered, 
4 had no recovery, and 2 were lost to follow-up. Of the 11 with recovery, 
improvement of the needle examination was seen in 7 patients, 2 did not show 
improvement, and 1 did not have the needle examination performed. 
Discussion 
This study revealed that a majority of our cohort presented with shoulder pain, and 
that trauma and neuralgic amyotrophy were the most common causes of SSN. A 5-
year retrospective study done in 65 patients with EMG-confirmed SSN also 
identified trauma and neuralgic amyotrophy as common etiologies.1 Although we 
defined sports-related and weight-lifting as separate etiologies, because weight-
lifting SSN is likely secondary to overuse, our group had a high rate of SSN from 
weight lifting/sports-related etiology whereas the Hills et al study1 had few cases.   
In our study, 48% of patients had reported abnormalities on shoulder MRI and 
43% had abnormal shoulder ultrasound studies. On detailed electrodiagnostic data 
review, we identified that suprascapular neuropathy is commonly associated with 
axillary neuropathy. Our study results are supported by a shoulder MRI study done 
on patients with Parsonage-Turner syndrome in which 50% of patients had both 
suprascapular and axillary nerve involvement.11 
Another interesting aspect of our study was that patients with isolated SSN were 
more likely to have sport-related and idiopathic etiologies whereas those with 
SSN+ axillary neuropathy was more likely to have a traumatic etiology (MVA and 
falls). Patients in the axillary neuropathy group had a higher rate of a limited range 
of motion because three of the four rotator cuff muscles (supraspinatus, 
infraspinatus and teres minor) were affected compared to only two affected 
(supraspinatus and infraspinatus) in the isolated SSN group.  
The diagnosis of SSN requires electrodiagnostic testing, and the data gathered on 
CMAP amplitudes may be related to the severity of the disease. Although one 
study found a direct relationship between EMG changes and treatment response,12 
neither our study nor Hill et al study1 found any significant relationship. The 
difference may lie in treatment. Antoniou et al12 reported that 68% of patients with 
SSN were treated operatively for compressive lesions and trauma whereas only 
35% had surgery in the Mayo Clinic study1 and 36% in our study. Perhaps these 
findings can be related to the relationship between the etiologic lesion causing the 
SSN, degree of compression, and therefore the EMG changes, and the mode of 
treatment. If there is a lesser degree of compression on the suprascapular nerve, 
with mild EMG changes, then there will not be an as great response to a surgical 
correction, as Antoniou et al12 found. However, when examining a cohort of 
patients in which a minority of patients undergo decompressive nerve surgery, the 
CMAP amplitudes may be less predictive, and recovery will be based on a variety 
of other factors.1   
In our study, 19% of patients had repeat electrodiagnostic study, with 65% of these 
showing recoveries. A total of 63% showed improvement in needle examination 
and only 27% showed improvement in NCS. These findings support the results of 
other studies where CMAP amplitude was helpful for the initial evaluation and 
severity of SSN but had little prognostic implication.1,12 All of our patients had 
needle examination of the infraspinatus muscle, which was a weakness of the Hill 
et al study where only a small portion (12%) of patients had infraspinatus muscle 
testing.  
It is important that patients with Sunderland grade III-V injuries are given an early 
referral to a nerve surgeon. There is a finite window in which surgical management 
can be performed, whether this involves nerve transfer or nerve grafting. 13, 14, 15, 16 
In contrast, tendon transfer (i.e., salvage procedure) to restore shoulder external 
rotation can be performed at any point after injury.  
Limitations of our study include the retrospective design and lack of suprascapular 
nerve conduction studies (CMAPs) in one-fourth of patients. Another limitation is 
the lack of documentation of pain level and exact measurements of range of motion 
during the follow-up visits. A third limitation is that the studies were performed by 
several clinicians. However, we were able to determine that most of the clinicians 
followed the guidelines and protocols established in our EMG laboratory to 
evaluate SSN. All patients underwent infraspinatus needle examinations and 87% 
underwent needle examination of the supraspinatus muscle. 
Conclusion 
Our study demonstrates the association of SSN with axillary neuropathy. This 
information serves to guide electromyographers to carefully evaluate patients with 
SSN who might need additional needle testing of axillary nerve-innervated 
muscles.    
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Table 1: Demographic and patient characteristics 





































        
Age at diagnosis Mean (SD) 47.4 (16.5) 44.9 (16.9) 49.6 (14.3) 60.3 (17.9) 53.5 (17.7) 58.00 75.00 
        
Sex Female 30 (34%) 19 (33%) 8 (35%) 1 (33%) 1 (50%) 1 (100%) 0 (0%) 
 Male 57 (66%) 38 (67%) 15 (65%) 2 (67%) 1 (50%) 0 (0%) 1 (100%) 
        
Etiology Idiopathic 21 (24%) 13 (23%) 2 (9%) 2 (67%) 2 (100%) 1 (100%) 1 (100%) 
 MVA 13 (15%) 5 (9%) 8 (35%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
 Fall 14 (16%) 5 (9%) 9 (39%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
 Sports related 10 (11%) 8 (14%) 2 (9%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
 Weight lifting 13 (15%) 12 (21%) 1 (4%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
 Other causes1 8 (9%) 8 (14%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
 Rotator cuff 
tear 
8 (9%) 6 (11%) 1 (4%) 1 (33%) 0 (0%) 0 (0%) 0 (0%) 
        
Rotator cuff tear No tear 49 (59%) 34 (62%) 10 (43%) 2 (100%) 2 (100%) 1 (100%) 0 (.%) 
 Small/partial 13 (16%) 8 (15%) 5 (22%) 0 (0%) 0 (0%) 0 (0%) 0 (.%) 
 Large/full 21 (25%) 13 (24%) 8 (35%) 0 (0%) 0 (0%) 0 (0%) 0 (.%) 
        
Side  Right 32 (37%) 17 (30%) 10 (43%) 2 (67%) 2 (100%) 0 (0%) 1 (100%) 
 Left 55 (63%) 40 (70%) 13 (57%) 1 (33%) 0 (0%) 1 (100%) 0 (0%) 
        
Pain  Yes 76 (87%) 49 (86%) 22 (96%) 2 (67%) 2 (100%) 1 (100%) 0 (0%) 
 No 11 (13%) 8 (14%) 1 (4%) 1 (33%) 0 (0%) 0 (0%) 1 (100%) 
1 For the other etiology, they were related to dislocations (n=2), "Pumping water" (n=1), Lipoma 
in the suprascapular fossa (n=1), seizure-related shoulder dislocation (n=1), desmoid tumor 




Table 2: Clinical and EMG findings 
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